B9D1: A Mitochondrial Protein Implicated in Disease (G27077)

Target Name: B9D1

NCBI ID: G27077

B9D1

B9D1: A Mitochondrial Protein Implicated in Disease

B9D1 (MKS9) is a protein that is expressed in various tissues throughout the body, including the brain, lungs, heart, and kidneys. It is a member of the superfamily of proteins known as the MIM (Mitochondrial Imports) proteins, which are involved in the import of proteins into the mitochondria. B9D1 has been shown to play a role in the regulation of mitochondrial function and metabolism, and is potential drug target (or biomarker) in several diseases.

The B9D1 protein is composed of 254 amino acid residues and has a calculated molecular mass of 33.1 kDa. It is expressed in a variety of tissues, including the brain, lungs, heart, and kidneys, and is also found in the cytoplasm of cultured cells. B9D1 is a mitochondrial protein, which means that it is localized to the mitochondria, where it is involved in the import of proteins into the mitochondria.

B9D1 has been shown to play a role in the regulation of mitochondrial function and metabolism. In addition to its role in protein import, B9D1 is also involved in the regulation of mitochondrial dynamics and in the control of mitochondrial protein homeostasis.

One of the most interesting functions of B9D1 is its role in the regulation of mitochondrial protein homeostasis. B9D1 has been shown to play a role in the stability of mitochondrial proteins, and is involved in the regulation of protein levels and localization within the mitochondria. This is important for maintaining the proper function of the mitochondria, which are responsible for the production of energy in the cell.

In addition to its role in protein homeostasis, B9D1 is also involved in the regulation of mitochondrial function and metabolism. B9D1 has been shown to play a role in the regulation of mitochondrial ATP production and in the control of mitochondrial energy metabolism. This is important for maintaining the proper function of the mitochondria, which is essential for the production and distribution of energy in the cell.

B9D1 is also involved in the regulation of cellular signaling pathways. B9D1 has been shown to play a role in the regulation of several cellular signaling pathways, including the regulation of cell adhesion, the regulation of cell proliferation, and the regulation of inflammation. This is important for the proper function of cells and for maintaining the health and integrity of the organism.

In conclusion, B9D1 is a protein that is expressed in various tissues throughout the body and is involved in the regulation of mitochondrial function and metabolism. B9D1 is a potential drug target (or biomarker) in several diseases, including cancer, neurodegenerative diseases, and cardiovascular disease. Further research is needed to fully understand the role of B9D1 in these diseases and to develop effective treatments.

Protein Name: B9 Domain Containing 1

Functions: Component of the tectonic-like complex, a complex localized at the transition zone of primary cilia and acting as a barrier that prevents diffusion of transmembrane proteins between the cilia and plasma membranes. Required for ciliogenesis and sonic hedgehog/SHH signaling (By similarity)

The "B9D1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about B9D1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets